N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine, >98.0%(HPLC), 1g

5-bromo-1-ethyl-3-methyl-1H-1,2,4-triazole, 95.0%, 10g

3-cyanobenzamide, 95.0%, 500g

N-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 100mg

n-Pentane, min. 99%, for synthesis, 2.5 l, glass packaging

2-Chloro-4-methylpyrimidin-5-ol, 95.0%, 500mg

3-(2-Fluorophenyl)-1,2-oxazol-5-amine, 95+%, 100mg

3-(Cyanomethyl)-2,4,5-trimethylthiophene>98.0%(GC)5g

2-Amino-7,9-dimethyl-9H-purin-7-ium-6-olate, 95.0%, 1g

2,2'-OXYBIS(N,N-DIETHYLETHANAMINE), 95.0%, 1g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucine>98.0%(HPLC)(T)5g

Etifoxine, 99.96%, 500mg

3-(5-Pyrimidinyl)benzoic acid, 95.0%, 5g